|
1
|
Lim HJ, Lee JY, Baek YH, Park MY, Youm DJ, Kim I, Kim MJ, Choi J, Sohn YH, Park JE, Yang YJ. Evaluation of Multiplex Rapid Antigen Tests for the Simultaneous Detection of SARS-CoV-2 and Influenza A/B Viruses. Biomedicines 2023; 11:3267. [PMID: 38137488 PMCID: PMC10741453 DOI: 10.3390/biomedicines11123267] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2023] [Revised: 12/05/2023] [Accepted: 12/08/2023] [Indexed: 12/24/2023] Open
Abstract
Single-target rapid antigen tests (RATs) are commonly used to detect highly transmissible respiratory viruses (RVs), such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza viruses. The simultaneous detection of RVs presenting overlapping symptoms is vital in making appropriate decisions about treatment, isolation, and resource utilization; however, few studies have evaluated multiplex RATs for SARS-CoV-2 and other RVs. We assessed the diagnostic performance of multiplex RATs targeting both the SARS-CoV-2 and influenza A/B viruses with the GenBody Influenza/COVID-19 Ag Triple, InstaView COVID-19/Flu Ag Combo (InstaView), STANDARDTM Q COVID-19 Ag Test, and STANDARDTM Q Influenza A/B Test kits using 974 nasopharyngeal swab samples. The cycle threshold values obtained from the real-time reverse transcription polymerase chain reaction results showed higher sensitivity (72.7-100%) when the values were below, rather than above, the cut-off values. The InstaView kit exhibited significantly higher positivity rates (80.21% for SARS-CoV-2, 61.75% for influenza A, and 46.15% for influenza B) and cut-off values (25.57 for SARS-CoV-2, 21.19 for influenza A, and 22.35 for influenza B) than the other two kits, and was able to detect SARS-CoV-2 Omicron subvariants. Therefore, the InstaView kit is the best choice for routine screening for both SARS-CoV-2 and influenza A/B in local communities.
Collapse
Affiliation(s)
- Ho-Jae Lim
- Department of Molecular Diagnostics, Seegene Medical Foundation, Seoul 04805, Republic of Korea; (H.-J.L.); (J.-Y.L.); (Y.-H.B.); (M.-Y.P.); (D.-J.Y.); (I.K.); (M.-J.K.); (J.C.); (Y.-H.S.)
- Department of Integrative Biological Sciences & BK21 FOUR Educational Research Group for Age-Associated Disorder Control Technology, Chosun University, Gwangju 61452, Republic of Korea
| | - Ji-Yoon Lee
- Department of Molecular Diagnostics, Seegene Medical Foundation, Seoul 04805, Republic of Korea; (H.-J.L.); (J.-Y.L.); (Y.-H.B.); (M.-Y.P.); (D.-J.Y.); (I.K.); (M.-J.K.); (J.C.); (Y.-H.S.)
| | - Young-Hyun Baek
- Department of Molecular Diagnostics, Seegene Medical Foundation, Seoul 04805, Republic of Korea; (H.-J.L.); (J.-Y.L.); (Y.-H.B.); (M.-Y.P.); (D.-J.Y.); (I.K.); (M.-J.K.); (J.C.); (Y.-H.S.)
| | - Min-Young Park
- Department of Molecular Diagnostics, Seegene Medical Foundation, Seoul 04805, Republic of Korea; (H.-J.L.); (J.-Y.L.); (Y.-H.B.); (M.-Y.P.); (D.-J.Y.); (I.K.); (M.-J.K.); (J.C.); (Y.-H.S.)
| | - Dong-Jae Youm
- Department of Molecular Diagnostics, Seegene Medical Foundation, Seoul 04805, Republic of Korea; (H.-J.L.); (J.-Y.L.); (Y.-H.B.); (M.-Y.P.); (D.-J.Y.); (I.K.); (M.-J.K.); (J.C.); (Y.-H.S.)
| | - Inhee Kim
- Department of Molecular Diagnostics, Seegene Medical Foundation, Seoul 04805, Republic of Korea; (H.-J.L.); (J.-Y.L.); (Y.-H.B.); (M.-Y.P.); (D.-J.Y.); (I.K.); (M.-J.K.); (J.C.); (Y.-H.S.)
| | - Min-Jin Kim
- Department of Molecular Diagnostics, Seegene Medical Foundation, Seoul 04805, Republic of Korea; (H.-J.L.); (J.-Y.L.); (Y.-H.B.); (M.-Y.P.); (D.-J.Y.); (I.K.); (M.-J.K.); (J.C.); (Y.-H.S.)
| | - Jongmun Choi
- Department of Molecular Diagnostics, Seegene Medical Foundation, Seoul 04805, Republic of Korea; (H.-J.L.); (J.-Y.L.); (Y.-H.B.); (M.-Y.P.); (D.-J.Y.); (I.K.); (M.-J.K.); (J.C.); (Y.-H.S.)
| | - Yong-Hak Sohn
- Department of Molecular Diagnostics, Seegene Medical Foundation, Seoul 04805, Republic of Korea; (H.-J.L.); (J.-Y.L.); (Y.-H.B.); (M.-Y.P.); (D.-J.Y.); (I.K.); (M.-J.K.); (J.C.); (Y.-H.S.)
| | - Jung-Eun Park
- Department of Integrative Biological Sciences & BK21 FOUR Educational Research Group for Age-Associated Disorder Control Technology, Chosun University, Gwangju 61452, Republic of Korea
| | - Yong-Jin Yang
- Department of Molecular Diagnostics, Seegene Medical Foundation, Seoul 04805, Republic of Korea; (H.-J.L.); (J.-Y.L.); (Y.-H.B.); (M.-Y.P.); (D.-J.Y.); (I.K.); (M.-J.K.); (J.C.); (Y.-H.S.)
| |
Collapse
|